‘An active future made possible by the power of science’

About NMD Pharma

 

NMD Pharma is a clinical-stage biotech company founded with a focus to deliver life-transforming therapies for people living with neuromuscular diseases.

We have a unique translational muscle electrophysiology platform leveraging in-depth know-how of muscle physiology and muscular disorders for discovering and developing first-in-class therapeutics in neuromuscular diseases with a significant unmet medical need.

NMD Pharma is the leading company utilizing ClC-1 Cl-ion channel inhibitors for neuromuscular diseases and currently has one clinical-stage product candidate for the treatment of myasthenia gravis.

We are more than 45 employees with expertise in all areas of drug development. We are headquartered in Aarhus, Denmark, and collaborate with internationally renowned companies and key opinion leaders in the field of neuromuscular diseases.

Vision

A future in which patients with neuromuscular disease live better and more independent lives.

Mission

NMD Pharma is dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular diseases.

Values

At NMD Pharma, we are passionate about movement. Inspired by patients’ resilience, and through ambitious and supportive collaborations, we can harness our innovative spirit to evolve and discover novel therapeutics for patients with neuromuscular diseases.

  • Passionate about movement

    We are passionate about turning science into novel therapeutics that enable patients with neuromuscular diseases to live more independent lives. We take part in the movement of patient communities and work with passion to establish NMD Pharma as a leading biotech company.

  • Innovate to evolve

    We are creative and innovative in our discovery of novel therapeutics by encouraging free thinking and knowledge sharing. We use our innovative spirit to evolve the treatment landscape for patients with movement disorders.

  • Inspired by resilience

    Our purpose is to help patients with neuromuscular diseases. Inspired by their resilience, we overcome challenges of bringing new therapeutics forward. When faced with challenges we do not quit but persevere and consider novel solutions to deliver on our mission.

  • Support and challenge

    We believe progress is made through collaboration, bringing together unique sets of knowledge and skills within our company and beyond. We believe the right balance of support and challenge is key in energizing each other on our journey.

NMD Pharma wins EY Entrepreneur Of The Year 2022 in the Life Sciences category
EY Entrepreneur Of The Year is the world's largest and most recognized growth creator competition. It is a celebration of the entrepreneurs who build and run successful and dynamic companies. More info

Watch the EY Entrepreneur Of The Year 2022 finalist video here

NMD Pharma wins the INCUBA award ‘Startup of the Year 2022’
The INCUBA award is an initiative that pays tribute to the investors and startups who take the lead and inspire others with their efforts in the startup ecosystem of Central Jutland. The award highlights startups and investors who deliver significant results and contribute to pushing the local ecosystem forward. It focuses on success, ambition, courage, innovation and those who go the extra mile for their business or investments. More info